Patents by Inventor Jacob Hartman

Jacob Hartman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REMOTE SENSING DEVICE AND SYSTEM FOR AGRICULTURAL AND OTHER APPLICATIONS
    Publication number: 20140120972
    Abstract: A radio-frequency enabled remote sensing device which can be deployed as a single device or a system of networked devices for gathering environmental data. The device is fully integrated and autonomous. The device operates using solar energy and is battery free due to power saving features of its control module and communications module. The device may operate in a sleep/wake cycle to further conserve power during low light conditions.
    Type: Application
    Filed: October 29, 2012
    Publication date: May 1, 2014
    Inventor: REINOUD JACOB HARTMAN
  • Variant Forms of Urate Oxidase and Use Thereof
    Publication number: 20130330803
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: August 21, 2013
    Publication date: December 12, 2013
    Applicant: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant forms of urate oxidase and use thereof
    Patent number: 8541205
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: May 1, 2012
    Date of Patent: September 24, 2013
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant form of urate oxidase and use thereof
    Patent number: 8465735
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: June 18, 2013
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant Forms of Urate Oxidase and Use Thereof
    Publication number: 20120309085
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: May 1, 2012
    Publication date: December 6, 2012
    Applicant: SAVIENT PHARMACEUTICALS, INC.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant form of urate oxidase and use thereof
    Patent number: 8293228
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: October 23, 2012
    Assignee: Savient Pharmaceuticals Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • VARIANT FORM OF URATE OXIDASE AND USE THEREOF
    Publication number: 20120225046
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Application
    Filed: April 20, 2012
    Publication date: September 6, 2012
    Applicant: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant forms of urate oxidase and use thereof
    Patent number: 8188224
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: May 29, 2012
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant form of urate oxidase and use thereof
    Patent number: 8178334
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: May 15, 2012
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
    Patent number: 8148123
    Abstract: A method for lowering elevated uric acid levels in patients is disclosed and consists of administering to the patients an intravenous injection of PEG-uricase having a dosage from about 4 to about 12 mg.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: April 3, 2012
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz, Claudia D. Rehrig, William Huang, Michael Hershfield
  • VARIANT FORM OF URATE OXIDASE AND USE THEREOF
    Publication number: 20120070876
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Application
    Filed: September 7, 2011
    Publication date: March 22, 2012
    Applicant: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant form of urate oxidase and use thereof
    Patent number: 8034594
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: October 11, 2011
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • VARIANT FORM OF URATE OXIDASE AND USE THEREOF
    Publication number: 20110217755
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Application
    Filed: May 13, 2011
    Publication date: September 8, 2011
    Applicant: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Variant form of urate oxidase and use thereof
    Patent number: 7964381
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: June 21, 2011
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • VARIANT FORM OF URATE OXIDASE AND USE THEREOF
    Publication number: 20110104751
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Application
    Filed: September 10, 2010
    Publication date: May 5, 2011
    Applicant: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Integrated domestic utility system
    Patent number: 7913331
    Abstract: An integrated domestic utility system is used to recycle grey water in a domestic house as a means to divert treated potable water away from non-potable uses, and in particular, toilet flushing. The system comprises a rainwater tank for storing rainwater collected from a roof top and a grey water tank to store grey water collected from a shower or bathtub. The rainwater is used to augment the grey water supply through a self regulating valve. Domestic water can also be used to replenish the grey water tank. A demand amount of grey water is pumped from the storage tank to at least one toilet tank. The system is controlled by a controller using pressure sensors and temperature sensors. The invention may include a solar heating circuit coupled to a domestic water heater. In one example of the invention, the system stores grey water in a bathtub and supplies it to toilet tank.
    Type: Grant
    Filed: March 9, 2008
    Date of Patent: March 29, 2011
    Inventor: Reinoud Jacob Hartman
  • Variant form of urate oxidase and use thereof
    Patent number: 7811800
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: October 12, 2010
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • INTEGRATED DOMESTIC UTILITY SYSTEM
    Publication number: 20090222981
    Abstract: An integrated domestic utility system is used to recycle grey water in a domestic house as a means to divert treated potable water away from non-potable uses, and in particular, toilet flushing. The system comprises a rainwater tank for storing rainwater collected from a roof top and a grey water tank to store grey water collected from a shower or bathtub. The rainwater is used to augment the grey water supply through a self regulating valve. Domestic water can also be used to replenish the grey water tank. A demand amount of grey water is pumped from the storage tank to at least one toilet tank. The system is controlled by a controller using pressure sensors and temperature sensors. The invention may include a solar heating circuit coupled to a domestic water heater. In one example of the invention, the system stores grey water in a bathtub and supplies it to toilet tank.
    Type: Application
    Filed: March 9, 2008
    Publication date: September 10, 2009
    Inventor: Reinoud Jacob HARTMAN
  • Variant Form of Urate Oxidase and Use Thereof
    Publication number: 20090209021
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Application
    Filed: April 11, 2006
    Publication date: August 20, 2009
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Solar powered controller
    Patent number: D672712
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: December 18, 2012
    Inventor: Reinoud Jacob Hartman